Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

The conclusion is that the IL-6/STAT3 activation affects p63 expression in healing wounds, which may help in hair follicle regeneration.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib treatment for hair loss may worsen acne.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Baricitinib is a promising treatment for alopecia areata.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

No cure exists for alopecia areata, and treatments are personalized.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Topical JAK inhibitors may help treat hair loss.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Higher STAT3 levels are found in hair loss areas, but not linked to hair loss severity.